Search
Ironwood Pharmaceuticals Inc
IRWDAdd to Watchlist
4.390USD
+0.360+8.93%
Close 11-06 16:00（ET）
725.40MMarket Cap
6.96P/E TTM
Ironwood Pharmaceuticals Inc (IRWD) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Ironwood Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
2 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
6.100USD+74.29%
IRWD Analyst Recommendation Trends
In the current month, IRWD has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. IRWD average Analyst price target in the last month is 6.100.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
IRWD Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, IRWD EPS is projected to reach 0.337 in FY2026Q4, following reported EPS of 0.363 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.24
0.36
0.32
0.34
0.29
Actual
0.25
0.31
0.36
--
--
Surprise
+3.94%
-12.37%
+12.24%
--
--
FAQs
What is Ironwood Pharmaceuticals Inc's expected revenue for the next quarter?
Ironwood Pharmaceuticals Inc's expected revenue is 130.33M.
What is Ironwood Pharmaceuticals Inc's price target?
Analysts forecast that Ironwood Pharmaceuticals Inc's price target is USD 6.10, with the highest forecast at USD 10.00 and the lowest forecast at USD 3.70.
How have Ironwood Pharmaceuticals IncIRWD's recent earnings per share performed?
The market expectation was USD 0.36, while Ironwood Pharmaceuticals IncIRWD's earnings per share (EPS) for the previous quarter was USD 0.31. EPS for the next quarter is expected at USD 0.34.
What is the analyst rating for Ironwood Pharmaceuticals Inc?
Based on the ratings of Ironwood Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.